Clinical Trial Update: An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating an administration method of human regular U-500 insulin (LY041001) in adults with Type 2 diabetes; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY041001 (insulin regular U-500)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-05-20